Immunic, Inc.
IMUX· Nasdaq
Released May 9, 2016, after the close
10-Q filed May 9, 2016, 39 days after period end · 0001628280-16-015949
| Metric | Q1 2016 | Q1 2015 | Q1 2014 | Q1 2013 |
|---|---|---|---|---|
| Net Income | -$9.59M | -$14.76M | -$10.75M | -$9.36M |
| EPS Diluted | -$0.31 | -$0.62 | -$24.49 | -$22.11 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Immunic, Inc. · CIK 1280776 · Engraved from SEC EDGAR